4//SEC Filing
Petersen Floyd F. 4
Accession 0001415889-25-015658
CIK 0001297184other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 6:39 PM ET
Size
9.1 KB
Accession
0001415889-25-015658
Insider Transaction Report
Form 4
Petersen Floyd F.
Director
Transactions
- Award
Common Stock
2025-06-02+5,122→ 78,031 total - Sale
Common Stock
2025-06-02$25.67/sh−500$12,835→ 72,909 total - Award
Stock Option (right to buy)
2025-06-02+11,402→ 11,402 totalExercise: $25.38Exp: 2035-06-02→ Common Stock (11,402 underlying)
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.39 to $25.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 2, 2026.
- [F4]All of the shares subject to the option vest on June 2, 2026.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001611286
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 6:39 PM ET
- Size
- 9.1 KB